Friday, May 11, 2018 11:22:49 PM
In the event they continue any type of toxic financing and virtually just over pay without relevant revenue increases in established markets such as Oregon is survivor mode. Basically stating lab revenues are stagnant on existing labs. At that point we merely become a "survivor" and acquisitions and new mergers begin to stop. Coming to a value IMO, is going to be challenging as they are building a foot print that really is desirable as a buyout candidate. If they complete 18 labs by year end and significant revenues are not obvious I believe $3.00 based on they still have an absolute footprint and licenses amassed. With vastly improving revenues $5+
In conclusion $3.00 on the survivor value providing we have 18 labs year end. Much higher if significant revenue increase is obvious. WW talking like 2019 or after Sept. 30 is the break out year.
FEATURED Are we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation • Nov 18, 2024 11:56 AM
FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM